Risk factors and clinical outcomes of multidrug-resistant acinetobacter baumannii bacteremia at a university hospital in Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 42, Issue 3, 2011, Pages 693-703

  Anunnatsiri, Siriluck ^a   Tonsawan, Pantipa ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Acinetobacter; Bacteremia; Multidrug resistant

Indexed keywords

EID: 79961064825     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Agbaht K, Diaz E, Munoz E, et al. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: a study comparing bacteremic vs nonbacteremic ventilator-associated pneumoniaCrit Care Med 2007; 35: 2064-70. (Pubitemid 47326442)
2. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumanniiNat Rev Microbiol 2007;5: 939-51. (Pubitemid 350131182)
3. Enoch DA, Summers C, Brown NM, et al. Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UKJ/ Hosp Infect 2008; 70: 109-18.
4. Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definition of multidrug-resistant MDR and pandrug-resistant PDR Acinetobacter baumannii and Pseudomonas aeruginosaJ Med Microbiol 2006a; 55: 1619-29. (Pubitemid 44902023)
5. Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literatureJ Hosp Infect 2006b; 64: 7-15. (Pubitemid 44161380)
6. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilitiesClin Infect Dis 2006; 42: 692-9. (Pubitemid 43271386)
7. Gootz TD, Marra A. Acinetobacter baumannii: an emerging multidrug-resistant threatExpert Rev Anti Infect Ther 2008; 6: 309-25.
8. Harris AD, Samore MH, Lipsitch M, Kaye KS, Perencevich E, Carmeli Y. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coliClin Infect Dis 2002; 34: 1558-63. (Pubitemid 34615439)
9. Jamulitrat S, Arunpan P, Phainuphong P. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii blood-stream infectionJ Med Assoc Thai 2009; 92: 413-9.
10. Kuo LC, Lai CC, Liao CH, et al. Multidrugresistant Acinetobacter baumannii bacteremia: clinical features, antimicrobial therapy and outcomeClin Microbiol Infect 2007; 13: 196-8.
11. Kwon KT, Oh WS, Song JH, et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemiJ Antimicrob Chemother 2007; 59: 525-30. (Pubitemid 47073460)
12. Lee NY, Lee HC, Ko NY, et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremiaInfect Control Hasp Epidemiol 2007; 28: 713-9.
13. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment optionsClin Infect Dis 2008; 46: 1254-63. (Pubitemid 351589912)
14. National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A5. Wayne, PA: NCCLS, 2000.
15. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogenClin Microbiol Rev 2008; 21: 538-82.
16. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumanniiAntimicrob Agents Chemother 2007; 51: 3471-84. (Pubitemid 47519332)
17. Pimentel JD, Low J, Styles K, Harris OC, Hughes A, Athan E. Control of an outbreak of multi-drug-resistant Acinetobacter baumannii in an intensive care unit and a surgical wardJ Hosp Infect 2005; 59: 249-53. (Pubitemid 40197788)
18. Playford EG, Craig JC, Iredell JR. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequencesJ Hosp Infect 2007; 65: 204-11.
19. Shih MJ, Lee NY, Lee HC, et al. Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case-control studyJ Microbiol Immunol Infect 2008; 41: 118-23.
20. Sunenshine RH, Wright MO, Maragakis LL, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalizationEmerg Infect Dis 2007; 13: 97-103. (Pubitemid 46057843)
21. Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977-2000Infect Control Hosp Epidemiol 2003; 24: 284-95. (Pubitemid 36538142)